Clinical Trials in Turnhout, Belgium
9 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Phase 2
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Neoplasms, Colon
GlaxoSmithKline120 enrolled31 locationsNCT06567782
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled564 locationsNCT07037459
Recruiting
Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Not Applicable
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
Older PeopleLocally Advanced Rectal Cancer
Jules Bordet Institute230 enrolled19 locationsNCT06052332
Recruiting
Phase 3
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
European Organisation for Research and Treatment of Cancer - EORTC220 enrolled94 locationsNCT05512364
Recruiting
Not Applicable
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
Non-metastasized Unresectable Pancreatic Carcinoma
Cancer Research Antwerp160 enrolled9 locationsNCT06691425
Recruiting
Phase 3
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes
Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven252 enrolled13 locationsNCT05569772
Recruiting
Not Applicable
Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC
Squamous Cell Carcinoma of Head and Neck
Universitaire Ziekenhuizen KU Leuven147 enrolled10 locationsNCT04688528